Pulse Biosciences (PLSE) Payables (2015 - 2025)

Pulse Biosciences' Payables history runs 11 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• On a quarterly basis, Payables rose 65.99% year-over-year to $2.8 million in Q4 2025; TTM through Dec 2025 was $2.8 million, a 65.99% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 65.99% from the prior year.
• Payables fell to $2.8 million in Q4 2025 per PLSE's latest filing, from $3.0 million in the prior quarter.
• Across five years, Payables topped out at $4.6 million in Q2 2021 and bottomed at $1.4 million in Q3 2023.
• The 5-year median for Payables is $2.2 million (2021), against an average of $2.4 million.
• Across the five-year window, Payables jumped 205.78% in 2021 and plunged 57.22% in 2022, its largest moves.
• Year by year, Payables stood at $1.8 million in 2021, then soared by 35.62% to $2.5 million in 2022, then retreated by 26.27% to $1.8 million in 2023, then decreased by 8.88% to $1.7 million in 2024, then jumped by 65.99% to $2.8 million in 2025.
• Per Business Quant, the three latest PLSE Payables figures stand at $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $2.7 million (Q2 2025).